LT3043814T - Antigenas ir jo gamybos būdas - Google Patents

Antigenas ir jo gamybos būdas

Info

Publication number
LT3043814T
LT3043814T LTEP14776600.0T LT14776600T LT3043814T LT 3043814 T LT3043814 T LT 3043814T LT 14776600 T LT14776600 T LT 14776600T LT 3043814 T LT3043814 T LT 3043814T
Authority
LT
Lithuania
Prior art keywords
antigen
production
Prior art date
Application number
LTEP14776600.0T
Other languages
English (en)
Inventor
Robin LÖVING
Jens Frauenfeld
Gunilla Karlsson HEDESTAM
Mathilda SJÖBERG
Henrik Garoff
Original Assignee
Salipro Biotech AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salipro Biotech AB filed Critical Salipro Biotech AB
Publication of LT3043814T publication Critical patent/LT3043814T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
LTEP14776600.0T 2013-09-13 2014-09-12 Antigenas ir jo gamybos būdas LT3043814T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1351057 2013-09-13
PCT/EP2014/069512 WO2015036549A1 (en) 2013-09-13 2014-09-12 Antigen and method for production thereof

Publications (1)

Publication Number Publication Date
LT3043814T true LT3043814T (lt) 2021-02-25

Family

ID=51626006

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP14776600.0T LT3043814T (lt) 2013-09-13 2014-09-12 Antigenas ir jo gamybos būdas

Country Status (7)

Country Link
US (1) US10159729B2 (lt)
EP (1) EP3043814B1 (lt)
HU (1) HUE052677T2 (lt)
LT (1) LT3043814T (lt)
PL (1) PL3043814T3 (lt)
SI (1) SI3043814T1 (lt)
WO (1) WO2015036549A1 (lt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2745834T3 (en) * 2012-12-18 2017-01-16 Salipro Biotech Ag Salipro particles
HUE052677T2 (hu) 2013-09-13 2021-05-28 Salipro Biotech AB Antigén és eljárás annak elõállítására
EP3284460A1 (en) 2016-08-19 2018-02-21 Salipro Biotech AG Saposin lipoprotein particles and libraries from crude membranes
AU2018331357A1 (en) 2017-09-18 2020-04-02 Bayer Healthcare Llc Methods of inactivation of viruses using N-methylglucamides and its Derivatives
EP3725304A1 (en) 2019-04-15 2020-10-21 Salipro Biotech AB Production of salipro particles
CN110564734A (zh) * 2019-09-28 2019-12-13 中国医学科学院病原生物学研究所 一种埃及血吸虫重组融合蛋白ShSAP及其在血吸虫病免疫诊断中的应用
WO2022090752A1 (en) * 2020-10-26 2022-05-05 Pécsi Tudományegyetem Vaccine platform
EP4123307A1 (en) 2021-07-22 2023-01-25 Salipro Biotech AB Methods for structure determination and drug design using salipro particles
WO2023001912A1 (en) 2021-07-22 2023-01-26 Salipro Biotech AB Methods for structure determination and drug design using salipro particles

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652339A (en) 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins
US20020177551A1 (en) 2000-05-31 2002-11-28 Terman David S. Compositions and methods for treatment of neoplastic disease
US7083958B2 (en) 2000-11-20 2006-08-01 The Board Of Trustees Of The University Of Illinois Membrane scaffold proteins
CN1474831A (zh) 2000-11-20 2004-02-11 ����ŵ˹������ѧ�йܻ� 膜支架蛋白
US7622437B2 (en) 2000-11-20 2009-11-24 The Board Of Trustees Of The University Of Illinois Tissue factor compositions and methods
US7592008B2 (en) 2000-11-20 2009-09-22 The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois Membrane scaffold proteins
JP4777873B2 (ja) 2003-02-14 2011-09-21 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド 親油性薬物送達ビヒクルおよびこれらの使用方法
US7834147B2 (en) 2003-04-28 2010-11-16 Childrens Hospital Medical Center Saposin C-DOPS: a novel anti-tumor agent
CA2541117A1 (en) 2003-10-01 2005-05-06 Children's Hospital & Research Center At Oakland Lipophilic drug delivery vehicle and methods of use thereof
US20070117179A1 (en) 2005-09-27 2007-05-24 Invitrogen Corporation In vitro protein synthesis systems for membrane proteins that include adolipoproteins and phospholipid-adolipoprotein particles
US20080248565A1 (en) 2007-03-01 2008-10-09 Invitrogen Corporation Isolated phospholipid-protein particles
BRPI0717475A2 (pt) 2006-10-20 2014-03-11 Childrens Hosp Medical Center Vesículas unilamelares de fosfolipídio elipsoidal de formação espontânea
US8999320B2 (en) 2008-01-30 2015-04-07 The Rockefeller University Nanoscale bound bilayers, methods of use and production
BRPI0823234A2 (pt) 2008-11-07 2019-09-24 Childrens Hospital Med Ct nanovesícula para liberação de um agente para uma membrana biológica e processo para direcionar um agente para uma membrana de uma célula ou um tecido.
US10525152B2 (en) 2009-10-09 2020-01-07 Signablok, Inc. Methods and compositions for targeted imaging
US20120190609A1 (en) 2010-08-30 2012-07-26 Martin Bader Method for producing a lipid particle, the lipid particle itself and its use
US9585972B2 (en) 2011-05-09 2017-03-07 Sherry L. Thornton Method for imaging a site of arthritis in an animal
HUE052677T2 (hu) 2013-09-13 2021-05-28 Salipro Biotech AB Antigén és eljárás annak elõállítására

Also Published As

Publication number Publication date
SI3043814T1 (sl) 2021-04-30
HUE052677T2 (hu) 2021-05-28
EP3043814A1 (en) 2016-07-20
US10159729B2 (en) 2018-12-25
WO2015036549A1 (en) 2015-03-19
PL3043814T3 (pl) 2021-05-17
US20160220664A1 (en) 2016-08-04
EP3043814B1 (en) 2020-12-02

Similar Documents

Publication Publication Date Title
IL291446A (en) Anti-trop2 antibodies and methods for their production
PL2967756T3 (pl) Aparat ortodontyczny oraz sposób jego wytwarzania
EP3006415B8 (en) Method for producing nanocement and nanocement
EP2987649A4 (en) TIRES AND METHOD FOR THE PRODUCTION OF TIRES
EP2987650A4 (en) TIRE AND METHOD FOR PRODUCING THE SAME
EP2947416A4 (en) SENSOR AND METHOD FOR THE MANUFACTURE THEREOF
EP2949783A4 (en) LUBICLE ELEMENT AND METHOD FOR THE PRODUCTION THEREOF
EP2979542A4 (en) METHOD FOR PRODUCING EXQUERMENT PROCESSING MATERIAL AND EXQUERMENT PROCESSING MATERIAL
HUE052677T2 (hu) Antigén és eljárás annak elõállítására
EP3045770A4 (en) FLAT RIBBON AND MANUFACTURING METHOD THEREFOR
IL239689A0 (en) A method for producing antibodies
GB201315777D0 (en) Novel method
HK1218893A1 (zh) 蛋白質的生產方法
EP2960338A4 (en) SUGAR SOLUTION PROCESS
EP2952895A4 (en) PROCESS FOR PRODUCING A MARKED ANTIBODY
EP2944375A4 (en) PRODUCTION OF MICROCAPSULE AND MICROCAPSULE
IL241779A0 (en) Method for protein production
EP2998330A4 (en) POLYMER AND METHOD FOR PRODUCING THE SAME
EP2868476A4 (en) PROCESS FOR PRODUCING PRINTED MEDIA
GB201300409D0 (en) Method
EP3051131A4 (en) COMPRESSOR AND METHOD FOR PRODUCING A COMPRESSOR
PL3069610T3 (pl) Ko-kryształ i sposób jego wytwarzania
EP2947664A4 (en) MAGNETIC MATERIAL AND METHOD FOR PRODUCING MAGNETIC MATERIAL
GB201310151D0 (en) Novel method
IL242505B (en) Method for producing specific oximes and oximethers